Testing disagreements hamper Ebola vax search; Admedus begins PhII trial of herpes jab;

> As the Ebola outbreak wanes, disagreements over the most effective testing methods may mean potential vaccines aren't thoroughly vetted. Story

> Admedus Limited will begin a Phase II study of its herpes vaccine this month. More

> Research Triangle Park, NC-based Argos Therapeutics ($ARGS) struck a deal with China-based Lummy Hong Kong to develop cancer immunotherapies in China. Report

> Daiichi Sankyo and Terumo announced their application for manufacturing and sales approval of an intradermal seasonal influenza vaccine in Japan. Release

> GeoVax will seek a dual pathway for advancing its HIV vaccine into human trials. Release

> Scientists believe a new HIV treatment pioneered using an antibody to attack the virus could lead to a vaccine to prevent the infection. Story

And Finally... Los Angeles artist Mary Beth Heffernan delivered a way for Ebola patients to see the faces of those helping. Story

Suggested Articles

Amid the COVID-19 pandemic, many teams of researchers are working on potential vaccines. We asked experts to assess progress—and point out challenges.

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Pfizer posted positive top-line results for a trial of its 20-valent pneumococcal vaccine, potentially setting up a filing by the end of 2020.